Press Releases

Leadership team additions
Atomwise Strengthens its Management Team, Adds Veteran Biopharma Leader David Thomson, Ph.D. as Chief Scientific Officer and Two Additional Senior Appointments

CSO, CFO, and GC added as technology-enabled pharma company bolsters growing management team and SAB SAN FRANCISCO, Calif. — January 25, 2022 — Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, announced today the appointment of David Thomson, Ph.D. as Chief Scientific Officer. Additional management team appointments include Jonathan Barr […]


January 25, 2022

Monsanto and Atomwise Collaborate to Discover New Crop Protection Options Using Artificial Intelligence Technology

Monsanto Company and Atomwise have formed a unique research collaboration to increase the speed and probability of discovering and developing new crop protection products using artificial intelligence. “Each growing season, farmers around the world are challenged with yield-robbing pests and diseases, yet the average crop protection product takes up to 11 years and more than […]


June 14, 2017
Atomwise Opens Applications for Historic AI Drug Discovery Awards

New initiative puts potential medicines chosen by artificial intelligence into the hands of one hundred researchers San Francisco, CA – April 19, 2017 – Atomwise Inc. seeks proposals from innovative university scientists to receive 72 potential medicines, generated specifically for their research by artificial intelligence. The Artificial Intelligence Molecular Screen (AIMS) program is designed to […]


April 9, 2017
Atomwise Raises $6 Million to Advance Artificial Intelligence for Drug Discovery

Atomwise Inc. today announced it has raised $6 million in seed funding from five leading, science-focused venture capital firms: Data Collective, which led the funding, Khosla Ventures, DFJ, AME Cloud Ventures, and OS Fund. “Having any one of these investors behind Atomwise would be remarkable,” said Co-founder and CEO, Dr. Abraham Heifets. “Having all five […]


June 3, 2015
Atomwise finds first evidence towards new Ebola treatments

Four months ago, Atomwise launched a virtual search for safe, existing medicines that could be repurposed to treat the Ebola virus. This week, the first evidence has been found that two drugs predicted by Atomwise’s artificial intelligence technology may significantly reduce Ebola infectivity. These drugs were intended for unrelated illnesses and their potential to treat […]


March 24, 2015
Atomwise Launches Search for New Ebola Treatments Using Artificial Intelligence

Atomwise Inc. and the University of Toronto announced today an initiative to search for new treatments for the Ebola virus using artificial intelligence. Deploying a groundbreaking research technology that learns and thinks like a human chemist, the team will use Canada’s most powerful supercomputer to simulate and analyze millions of potential medicines in a matter […]


November 4, 2014